|
Sign In to gain access to subscriptions and/or personal tools.
|
Parvovirus B19 infection associated with the production of antineutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL)
T-N K Chou
T-C Hsu
R-M Chen
Department of Medicine and Institute of Immunology, Chung Shan Medical and Dental College, Taichung, Taiwan
L-I Lin
School of Medical Technology, College of Medicine, National Taiwan University, Taipei, Taiwan
G J Tsay
Department of Medicine and Institute of Immunology, Chung Shan Medical and Dental College, 110 Sec 1, Chien Kuo N. Road, Taichung 402, Taiwan. Tel: (/ 886) 4 3248160; Fax: (/ 886) 4 4723229; gjt{at}mercury.csmc.edu.tw
We described four patients who had clinical diagnosis of erythema infectiosum and presented with skin rash, polyarthralgia, polyarthritis, and mild fever. Anti-parvovirus B19 IgM and IgG antibodies were found in all four patients and parvovirus B19 DNA was detected in three of the four patients by polymerase chain reaction (PCR) in sera using standard methods. Anticardiolipin antibody (aCL) was positive in three of the four patients included three with anti-b2 glycoprotein I (b2GPI). The immunoglobulin isotype of aCL was found to be IgM. Anti-neutrophil cytoplasmic antibody (ANCA) included three p-ANCA and one c-ANCA was detected in all four patients by indirect immunofluoresence (IIF). Both anti-proteinase 3 (PR3) and anti-myeloperoxidase (MPO) antibodies were found in two patients whom had polyarthritis for more than 6 months. These data indicate parvovirus B19 may be linked to the induction of an autoimmune response.
Key Words: parvovirus B19 infection ANCA aCL autoimmune response
Lupus, Vol. 9, No. 7,
551-554 (2000)
DOI: 10.1177/096120330000900714

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. A.F. de Lind van Wijngaarden, L. van Rijn, E. C. Hagen, R. A. Watts, G. Gregorini, J. W. C. Tervaert, A. D. Mahr, J. L. Niles, E. de Heer, J. A. Bruijn, et al.
Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known
Clin. J. Am. Soc. Nephrol.,
January 1, 2008;
3(1):
237 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Hermann, U Demel, D Stunzner, E Daghofer, G Tilz, and W Graninger
Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall
Ann Rheum Dis,
April 1, 2005;
64(4):
641 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Teixeira, A. Mahr, F. Jaureguy, L.-H. Noel, H. Nunes, A. Lefort, S. Barry, P. Deny, and L. Guillevin
Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis
Rheumatology,
February 1, 2005;
44(2):
247 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Boura, K. Tselios, P. Skendros, and J. Kountouras
Antiphospholipid Syndrome in Greece: Clinical and Immunological Study and Review of the Literature
Angiology,
July 1, 2004;
55(4):
421 - 430.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Eden, A. Mahr, A. Servant, N. Radjef, S. Amard, L. Mouthon, A. Garbarg-Chenon, and L. Guillevin
Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study
Rheumatology,
May 1, 2003;
42(5):
660 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-C. Hsu and G. J. Tsay
Human parvovirus B19 infection in patients with systemic lupus erythematosus
Rheumatology,
February 1, 2001;
40(2):
152 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|